Peter Bernstein, PhD is a consultant in medicinal chemistry with more than 30 years of experience in drug development and discovery at ICI Pharmaceuticals through its spin-off as Zeneca Pharmaceuticals and subsequent merger with Astra Pharmaceuticals to form AstraZeneca Pharmaceuticals.
Former Senior Principal Scientist of CNS Chemistry, AstraZeneca Pharmaceuticals